Clorox Company (The) (CLX) Upgraded to “Outperform” at Consumer Edge

Consumer Edge upgraded shares of Clorox Company (The) (NYSE:CLX) from a neutral rating to an outperform rating in a research report report published on Friday morning.

CLX has been the subject of several other research reports. Deutsche Bank AG reissued a hold rating and issued a $137.00 price target (up previously from $126.00) on shares of Clorox Company (The) in a research note on Saturday, July 22nd. Jefferies Group LLC restated a hold rating and set a $132.00 target price on shares of Clorox Company (The) in a research report on Wednesday, November 1st. Zacks Investment Research lowered Clorox Company (The) from a hold rating to a sell rating in a research report on Wednesday, October 4th. BMO Capital Markets restated a buy rating and set a $150.00 target price on shares of Clorox Company (The) in a research report on Thursday, October 5th. Finally, Royal Bank of Canada restated a hold rating and set a $115.00 target price on shares of Clorox Company (The) in a research report on Sunday, October 8th. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the stock. The company currently has a consensus rating of Hold and an average price target of $128.72.

Shares of Clorox Company (CLX) traded up $1.37 during mid-day trading on Friday, hitting $132.05. The stock had a trading volume of 718,800 shares, compared to its average volume of 815,927. The firm has a market capitalization of $16,849.70, a PE ratio of 23.55, a price-to-earnings-growth ratio of 3.56 and a beta of 0.39. The company has a current ratio of 1.10, a quick ratio of 0.77 and a debt-to-equity ratio of 3.02. Clorox Company has a 12 month low of $111.77 and a 12 month high of $141.76.

Clorox Company (The) (NYSE:CLX) last issued its quarterly earnings results on Wednesday, November 1st. The company reported $1.46 earnings per share for the quarter, beating the consensus estimate of $1.41 by $0.05. The company had revenue of $1.50 billion during the quarter, compared to analysts’ expectations of $1.48 billion. Clorox Company (The) had a return on equity of 161.59% and a net margin of 11.84%. The business’s quarterly revenue was up 4.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.36 earnings per share. equities analysts forecast that Clorox Company will post 5.58 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “Clorox Company (The) (CLX) Upgraded to “Outperform” at Consumer Edge” was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this piece can be read at https://www.dispatchtribunal.com/2017/11/11/clorox-company-the-clx-upgraded-to-outperform-at-consumer-edge.html.

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 13th. Investors of record on Wednesday, October 25th will be given a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.54%. The ex-dividend date of this dividend is Tuesday, October 24th. Clorox Company (The)’s payout ratio is 61.88%.

In other Clorox Company (The) news, SVP Matthew T. Laszlo sold 20,051 shares of the firm’s stock in a transaction on Wednesday, November 8th. The stock was sold at an average price of $130.46, for a total value of $2,615,853.46. Following the completion of the sale, the senior vice president now directly owns 10,896 shares of the company’s stock, valued at $1,421,492.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, COO Dawn C. Willoughby sold 2,158 shares of the firm’s stock in a transaction on Tuesday, August 29th. The stock was sold at an average price of $138.00, for a total value of $297,804.00. The disclosure for this sale can be found here. Insiders have sold 41,293 shares of company stock valued at $5,560,303 over the last ninety days. 1.00% of the stock is currently owned by company insiders.

A number of large investors have recently added to or reduced their stakes in the business. Jacobi Capital Management LLC increased its position in Clorox Company (The) by 0.3% in the first quarter. Jacobi Capital Management LLC now owns 1,282 shares of the company’s stock worth $172,000 after buying an additional 4 shares during the last quarter. Valley National Advisers Inc. increased its position in Clorox Company (The) by 0.6% in the second quarter. Valley National Advisers Inc. now owns 865 shares of the company’s stock worth $115,000 after buying an additional 5 shares during the last quarter. Bernzott Capital Advisors increased its position in Clorox Company (The) by 0.4% in the second quarter. Bernzott Capital Advisors now owns 1,607 shares of the company’s stock worth $214,000 after buying an additional 7 shares during the last quarter. Janney Capital Management LLC boosted its holdings in shares of Clorox Company (The) by 0.5% in the second quarter. Janney Capital Management LLC now owns 1,611 shares of the company’s stock worth $214,000 after acquiring an additional 8 shares during the period. Finally, Financial Advisory Service Inc. boosted its holdings in shares of Clorox Company (The) by 0.3% in the second quarter. Financial Advisory Service Inc. now owns 4,012 shares of the company’s stock worth $535,000 after acquiring an additional 12 shares during the period. 71.54% of the stock is owned by institutional investors and hedge funds.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply